The results demonstrated that the high expression level of MAGE-D4 mRNA in gliomas was also significantly related to the poor prognosis of patients (OS HR = 0.65, 95% CI = 0.50–0.83, logrank P = 0.001). The gene discussed is MAGED4; the disease is central nervous system cancer.